Xtx Topco LTD Capricor Therapeutics, Inc. Transaction History
Xtx Topco LTD
- $2.23 Billion
- Q2 2025
A detailed history of Xtx Topco LTD transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 27,499 shares of CAPR stock, worth $207,342. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,499
Previous 54,870
49.88%
Holding current value
$207,342
Previous $520,000
47.5%
% of portfolio
0.01%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding CAPR
# of Institutions
144Shares Held
12.4MCall Options Held
4.99MPut Options Held
5.52M-
Vanguard Group Inc Valley Forge, PA2.31MShares$17.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$12.3 Million0.0% of portfolio
-
State Street Corp Boston, MA1.47MShares$11.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA963KShares$7.26 Million0.0% of portfolio
-
Morgan Stanley New York, NY551KShares$4.15 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $184M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...